Literature DB >> 1727879

Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. Working Group on Steroid Use, Antimicrobial Agents Committee, Infectious Diseases Society of America.

J E McGowan1, P J Chesney, K B Crossley, F M LaForce.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1727879     DOI： 10.1093/infdis/165.1.1

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  17 in total

1.  Dexamethasone effects in the Strongyloides venezuelensis infection in a murine model.

Authors:  Eleuza R Machado; Daniela Carlos; Carlos A Sorgi; Simone G Ramos; Daniela I Souza; Edson G Soares; Julia M Costa-Cruz; Marlene T Ueta; David M Aronoff; Lúcia H Faccioli
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  Meta-analysis redux-steroids and meningitis revisited.

Authors:  P L Havens
Journal:  West J Med       Date:  1992-07

3.  Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda.

Authors:  Harriet Mayanja-Kizza; Edward Jones-Lopez; Alphonse Okwera; Robert S Wallis; Jerrold J Ellner; Roy D Mugerwa; Christopher C Whalen
Journal:  J Infect Dis       Date:  2005-02-08       Impact factor: 5.226

4.  Steroids treatment of granulomatous hepatitis complicating Coxiella burnetii acute infection.

Authors:  M Crespo; B Sopeña; J Bordón; J de la Fuente; M Rubianes; C Martinez-Vázquez
Journal:  Infection       Date:  1999 Mar-Apr       Impact factor: 3.553

Review 5.  Role of glucocorticosteroids in the treatment of infectious diseases.

Authors:  J Thompson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993       Impact factor: 3.267

Review 6.  Pathogenesis and pathophysiology of bacterial meningitis.

Authors:  A R Tunkel; W M Scheld
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

7.  Evidence-based medicine.

Authors:  D W MacPherson
Journal:  CMAJ       Date:  1995-01-15       Impact factor: 8.262

8.  Complicated urinary tract infection in adults.

Authors:  L E Nicolle
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-11       Impact factor: 2.471

Review 9.  Treatment of Legionnaires' disease. Current recommendations.

Authors:  J Roig; A Carreres; C Domingo
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

10.  L-651,392, a potent leukotriene inhibitor, controls inflammatory process in Escherichia coli pyelonephritis.

Authors:  M Tardif; D Beauchamp; Y Bergeron; C Lessard; P Gourde; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.